🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04691037
Recruiting Observational

CCTA Improves Clinical Management of Stable Chest Pain

NCT04691037 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Chest Hospital
Phase
Observational
Started
2016-01-01
Last updated
2024-03-28

Condition(s) studied

Coronary Computed Tomography AngiographyStable Chest PainOptimal Medical TherapyInvasive Coronary AngiographyRevascularizationMajor Adverse Cardiovascular EventsCoronary Artery Disease

Investigational drug(s) / intervention(s)

CCTA

CCTA: All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary.

Study summary

The investigator aims to prospectively enroll patients who were referred for coronary computed tomography angiography (CCTA) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary. This study will determine if CCTA-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * symptomatic patients with SCP suspected of obstructive CAD. * referred for CCTA for the assessment of SCP. * ≥18 years of age. * signed informed consent. Exclusion Criteria: * acute coronary syndromes * previous CAD or coronary revascularization * nonsinus rhythm * cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Beijing Chaoyang Hospital Beijing Beijing Municipality Recruiting
Hebei Petrochina Central Hospital Langfang Hebei Recruiting
Tianjin Chest Hospital Tianjin Tianjin Municipality Recruiting
Tianjin First Central Hospital Tianjin Tianjin Municipality Recruiting

More Tianjin Chest Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04691037 on ClinicalTrials.gov ↗ ← All trials in China